Connect with us

Technology

Kaia Health Appoints Adam Pellegrini as Global CEO And Launches The First Digital Pulmonary Rehab Program In Partnership With The COPD Foundation

Published

on

NEW YORK, Oct. 19, 2024 /PRNewswire/ — Kaia Health (Kaia), a leading digital health company, announces the appointment of Adam Pellegrini as its new Chief Executive Officer. Pellegrini brings a wealth of experience in digital health and a proven track record of driving innovation and growth. His appointment coincides with the highly anticipated US launch of Kaia Breathe, a digital-first pulmonary rehab program designed to support patients with COPD and other respiratory diseases.

Kaia Health Appoints Adam Pellegrini as Global CEO; Launches First Digital Pulmonary Rehab Program With COPD Foundation

Pellegrini brings more than two decades of experience in digital health to Kaia, having held executive roles at industry leaders such as Microsoft, Fitbit, Walgreens, CVS Health, and most recently, Jasper Health. His strategic vision and deep expertise in consumer behavior within the digital health landscape position him as the ideal leader to guide Kaia Health through its next phase of growth.

As part of the launch of Kaia Breathe, Kaia is proud to announce a partnership with the COPD Foundation, joining them on their mission to help millions of people live longer and healthier lives by advancing research, advocacy, and awareness to stop COPD, bronchiectasis, and NTM lung disease.

“More than 30 million people in the United States have COPD, and many struggle to manage their condition. Kaia Health’s digital-first rehabilitation model is already improving the lives of thousands, and I see a similar opportunity in pulmonary rehab to ease the disease burden for COPD patients and their caregivers,” said Pellegrini. “Today, in partnership with the COPD Foundation, we are launching Kaia Breathe, a digital solution that delivers consistent, clinically impactful therapy at scale coupled with engaging, habit-building technology”

“Innovative technologies like Kaia Breathe are transforming the landscape of pulmonary rehabilitation, providing individuals with greater access to personalized care that meets their unique needs,” said Jean Wright, M.D., MBA, CEO of the COPD Foundation. “By combining our expertise in COPD and Kaia Health’s digital solutions, this collaboration aims to make a lasting impact on the lives of millions living with chronic lung diseases.”

Kaia Breathe marks a significant advancement in managing chronic respiratory conditions through pulmonary rehabilitation. The program delivers personalized exercise therapy and condition education, supported by coaches and artificial intelligence motion tracking technology, enabling patients to manage their symptoms more effectively and improve their quality of life. With the US launch of this solution, Kaia Health aims to empower millions of COPD patients to manage their health and well-being from the comfort of their homes.

Pellegrini will officially launch Kaia Breathe at the HLTH conference in Las Vegas this week.

To learn more about Kaia Health, please visit kaiahealth.com. For more information about the COPD Foundation, visit copdfoundation.org.

About Kaia Health:
Kaia Health is the world’s largest digital therapeutics company on a mission to empower millions of people to live their healthiest lives. Kaia Health partners with leading health plans, employers, and providers, covering nearly 65 million lives around the world. Kaia’s evidence-based treatments, covering a range of conditions, including MSK and COPD, are powered by proprietary AI, motion analysis technology, and clinical expertise. Kaia’s app is designed to work on your smartphone or tablet – delivering the most accessible, effective, and equitable experience available. Across 20 clinical trials, Kaia Health has demonstrated effectiveness and safety on par with traditional care with as much as 80% reduction in cost, as recognized by the Program Validation from the independent Validation Institute.

About the COPD Foundation:
The COPD Foundation is a nonprofit organization whose mission is to help millions of people live longer and healthier lives by advancing research, advocacy, and awareness to stop COPD, bronchiectasis, and NTM lung disease. The Foundation does this through scientific research, education, advocacy, and awareness to prevent disease, slow progression, and find a cure. For more information, visit copdfoundation.org, or follow us on Twitter and LinkedIn.

View original content to download multimedia:https://www.prnewswire.com/news-releases/kaia-health-appoints-adam-pellegrini-as-global-ceo-and-launches-the-first-digital-pulmonary-rehab-program-in-partnership-with-the-copd-foundation-302280961.html

SOURCE Kaia Health

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Honoring Dr. J. Craig Venter’s Legacy, Human Longevity Launches Clinical-Grade $599 Whole Genome Sequencing Report with AI-Enhanced Insights for Proactive Disease Prevention

Published

on

By

SOUTH SAN FRANCISCO, Calif., May 11, 2026 /PRNewswire/ — Human Longevity, Inc. today announced the launch of its new Clinical-Grade $599 Whole Genome Sequencing Report, designed to bring advanced genomic medicine and AI-driven disease prevention to the general population.

Despite major advances in medicine, most diseases today are still identified only after symptoms appear — often limiting opportunities for earlier intervention and prevention. While genomic sequencing has generated vast amounts of biological data, one of healthcare’s biggest challenges has been translating that data into actionable health insights at scale.

Human Longevity’s new offering honors the legacy of Dr. J. Craig Venter, whose pioneering work helped decode the first human genome and transform modern medicine.

More than two decades ago, the Human Genome Project required over $3 billion and years of international effort to decode a single human genome. Today, Human Longevity is making a clinical grade genome sequencing broadly accessible with a comprehensive AI-enhanced genomic insight platform for just $599.

Dr. Venter long predicted that the human genome would play an increasingly important role in managing individual health and preventing disease. In recent years, a growing body of global scientific research has continued to validate this vision, demonstrating that genomics is becoming a foundational tool for predicting disease risk, guiding prevention strategies, and enabling more personalized healthcare.

“Dr. Venter believed that genomics would fundamentally transform medicine from reactive sick care to a proactive healthcare model,” said Wei-Wu He, Ph.D. Executive Chairman of Human Longevity Inc. “A decade ago, he founded Human Longevity to combine whole genome sequencing with advanced imaging, including Whole Body MRI, multi-omics data, longitudinal health data and AI, to help people live longer, healthier lives. We are proud to continue that mission by democratizing access to decades of work led by Human Longevity.”

Over the last decade, Human Longevity has invested more than $600 million building one of the world’s most comprehensive longitudinal health datasets. The company has collected and analyzed data from more than 10,000 individuals over a 10-year period, enabling the development of proprietary AI-driven insights focused on major age-related chronic diseases such as cardiovascular disease, cancer, and dementia.

The new Clinical-Grade Whole Genome Sequencing Insight Report is designed to provide individuals with actionable insights into inherited disease risks, carrier status, pharmacogenomics, longevity-associated traits, and personalized disease prevention opportunities.

“Our vision is simple,” added Dr. He. “Every individual should have access to their genome and AI-powered health insights. The genome is the foundation of modern preventive medicine.”

The new service will be available nationwide immediately through Human Longevity’s website.

For more information, visit:

Human Longevity Website

About Human Longevity, Inc.

Founded in 2013, Human Longevity, Inc. is a biotechnology company at the forefront of integrating genomics, artificial intelligence, and multimodal diagnostics to extend human healthspan founded by genomics pioneer J. Craig Venter. HLI delivers comprehensive, data-driven evaluations designed to identify and mitigate disease risk long before symptoms arise. The company is committed to redefining healthcare through AI-driven proactive diagnostics and personalized preventive care.

To learn more, visit http://www.humanlongevity.com/.

Media Contact:
media@humanlongevity.com
www.humanlongevity.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/honoring-dr-j-craig-venters-legacy-human-longevity-launches-clinical-grade-599-whole-genome-sequencing-report-with-ai-enhanced-insights-for-proactive-disease-prevention-302768424.html

SOURCE Human Longevity, Inc.

Continue Reading

Technology

DocuPet Launches AnimalsFirst Integration to Increase Pet Protection Nationwide

Published

on

By

SYRACUSE, N.Y., May 11, 2026 /PRNewswire/ — DocuPet is proud to announce a new strategic partnership with AnimalsFirst, marking the official launch of an integrated solution designed to connect animal welfare organizations directly with DocuPet’s National Pet Registry. This collaboration represents a significant milestone in DocuPet’s long-term vision to streamline shelter operations while expanding pet registration across North America.

For several years, DocuPet has invested in building a flexible, scalable software infrastructure capable of supporting integrations with leading shelter management systems. With the continued growth of the National Pet Registry and the National Animal Shelter Network (NASN), DocuPet is now positioned to activate these capabilities AnimalsFirst offers a highly customizable shelter management platform that supports adoptions, foster coordination, medical tracking, and field services for approximately 120 animal welfare organizations. Through this partnership, shelter partners using AnimalsFirst will be able to directly register adopters and their pets into the National Pet Registry through a streamlined backend integration.

Expanding Protection Through the National Pet Registry

At the core of this partnership is a shared commitment to increasing the number of pets enrolled in DocuPet’s National Pet Registry. Registration is a critical step in protecting pets, ensuring that accurate, up-to-date ownership information is readily accessible when a lost animal is found.

DocuPet’s HomeSafe® service plays a vital role in this effort. Each registered pet receives a free tag with a unique code linked to its secure online profile. When a lost pet is found, anyone can use the information on the tag to quickly initiate the reunification process. This immediate connection dramatically improves return-to-home rates and reduces the time pets spend in shelters.

Getting visible identification tags on pets is one of the simplest yet most effective ways to keep animals safe, and the success is multiplied when using DocuPet tags that offer superior reunification benefits. By increasing registration at the point of adoption and throughout the community, DocuPet and its partners are helping ensure more pets have the protection they need.

“We are thrilled to partner with AnimalsFirst and to be able to offer our registration program to shelters and pet owners utilizing their platform,” said Jackie Rose, CSO of DocuPet. “This enhanced and streamlined process will allow pet owners to easily register to receive the protection benefits of having a free pet identification tag, connected to our 24/7 lost pet recovery system.” 

Strengthening the Animal Welfare Ecosystem

This integration supports a broader, interconnected animal welfare ecosystem that includes pet owners, shelters, and animal control agencies. For pet owners, it provides peace of mind and an easy way to safeguard their animals. For shelters, it helps reduce overcrowding and administrative burden by increasing successful reunifications. For animal control officers, it offers a fast, reliable method to identify and return lost pets in the field.

By embedding registration opportunities directly into shelter workflows, DocuPet and AnimalsFirst are helping create a more proactive, efficient system; one that prioritizes prevention, accelerates reunification, and ultimately improves outcomes for animals and the communities that care for them.

This partnership underscores DocuPet’s commitment to leveraging technology to support animal welfare organizations, reduce administrative burden, and ensure more pets are protected through reliable identification and recovery services.

About DocuPet
DocuPet is the largest and fastest-growing pet registration and reunification platform in North America, providing official pet licensing services to more than 300 jurisdictions. DocuPet provides free lost pet services through HomeSafe®, and a unique product offering with an AI-powered pet tracker, designer pet tags, and other pet products/services. DocuPet is transforming how communities support animal welfare through inventive thinking and pioneering technology.

About AnimalsFirst
AnimalsFirst is a customizable shelter management software platform designed to support the operational needs of animal welfare organizations, including adoption management, foster coordination, medical tracking, and field services.

For more information, visit https://partnerships.docupet.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/docupet-launches-animalsfirst-integration-to-increase-pet-protection-nationwide-302767346.html

SOURCE DocuPet

Continue Reading

Technology

Boundary Labs Announces $2M Pre-Seed Led by Galaxy Ventures to Launch Verifiable Institutional Stablecoin, USBD

Published

on

By

The current stablecoin landscape often forces institutions to rely on trust in opaque centralized models, off-chain systems, and reserves. Boundary is solving this by introducing a protocol where verifiability is the core product feature.

NEW YORK, May 11, 2026 /PRNewswire/ — Boundary today announced the closing of a $2M USD pre-seed funding round led by Galaxy Ventures. Joining the round are a cohort of leading institutional finance partners and angels, including VCs BlackWood and FirstBlock Capital. The capital will accelerate the launch of USBD, a novel stablecoin protocol engineered specifically for financial and blockchain institutions and approved participants who require a new standard of on-chain verifiability in the >$300B stablecoin market.

“Trust but verify” is a phrase core to the on-chain industry as it champions a critical principle where institutions and retail should not just trust but also verify that what a protocol says and offers is real. Without real verifiable, there is no real trust. This is paramount to the industry’s security, stability, and scalability. However, the current stablecoin landscape often forces institutions to rely on trust rather than working with immediately verifiable products and reserves.

Boundary is solving this by introducing a protocol where verifiability is the core product feature. By providing institutional counterparties with clear technical documentation and a framework for verifiability of reserves and stablecoin performance, Boundary allows institutions to move on-chain with the certainty required for large-scale institutional stablecoin use cases like treasury management, regulated wrappers, and on-chain collateral.

The Boundary Protocol introduces a sophisticated structure designed for institutional compliance and operational clarity:

On-chain Verifiability: Unlike first generation stablecoins, USBD is built for continuous auditability of financial fundamentals, providing institutions with the data-driven confidence needed for professional participation and fiduciary products.Institutional-Only Onboarding: Access will be facilitated through a dedicated dApp designed for rigorous KYC and KYB workflows, ensuring only qualifying institutional participants enter the ecosystem in the institutional growth phase.Strategic Ecosystem Support: As a participant in several institutional partnerships, soon to be announced, and having completed a security audit by Cyfrin, Boundary has quickly positioned itself as the project with the leading technology to ensure protocol integrity.

“Boundary represents a proposition that speaks the language of institutional finance,” said Matthew Mezger, Co-Founder of Boundary. “By prioritizing verifiability and partnering with Galaxy Ventures, we are providing the professional-grade infrastructure necessary to reach our initial milestone of $100M in Total Value Locked (TVL) in 2026”.

Following today’s announcement, and building on a successful proof-of-concept for the protocol’s self-funding capability through derisked decentralized market participation, Boundary will initiate a Private Placement Campaign to onboard initial institutional partners.

“Institutional adoption of stablecoins is not only well underway but already proving its value in real-world use cases. With a long runway of growth still ahead, unlocking the full potential of stablecoins requires infrastructure that is not just secure, but inherently verifiable,” said Danny Slutsky, Investor at Galaxy Ventures. “Boundary’s focus on professional participants and its goal to bridge the gap between traditional finance and blockchain makes it a promising player in growing the stablecoin market.”

About Boundary: Boundary Labs is mandated by the Boundary Foundation and Boundary OpCo to lead the design, development, and commercial representation of the Boundary project. Based in New York City, the firm provides financial institutions and professional participants with secure, verifiable access to the USBD stablecoin and the broader Boundary Protocol ecosystem. For more information, visit https://boundary.finance/.

View original content to download multimedia:https://www.prnewswire.com/news-releases/boundary-labs-announces-2m-pre-seed-led-by-galaxy-ventures-to-launch-verifiable-institutional-stablecoin-usbd-302767720.html

SOURCE Boundary Labs International, Inc.

Continue Reading

Trending